However, inactivation of MMR genes like MSH3 and MSH5 by methylation and single nucleotide polymorphisms (SNPs) has been associated with increased sensitivity to cisplatin-based chemotherapy in small cell lung carcinoma (J.-Y. Here, MSH3 is linked to small cell lung carcinoma.